VIB Main
Part of the conference series

Medical Biotechnology

24-25 May 2018, Ghent, Belgium
MedBiotech - Campaign visual
Lievekaai - Ghent
Lievekaai - Ghent
Saint-Michaelsbridge Ghent
Saint-Michaelsbridge Ghent
City pavilion - Ghent (Architects: Robbrecht & Daem / Marie-José Van Hee)
City pavilion - Ghent (Architects: Robbrecht & Daem / Marie-José Van Hee)
Restaurant LOF Ghent
Restaurant LOF Ghent
Speakers Medbiotech18 Ghent
Speakers Medbiotech18 Ghent
Kouter Ghent
Kouter Ghent
Aula Ghent University - Venue
Aula Ghent University - Venue
Castle of the Counts Ghent
Castle of the Counts Ghent
Medical Biotechnology

"Medical Biotechnology is in an era of rapid transformation because of new disruptive technologies for early diagnosis and more effective therapeutic intervention, even in established chronic diseases," said Nico Callewaert of the VIB-UGent Center for Medical Biotechnology and organizing committee member of this conference. "VIB organizes this focus meeting to provide cutting edge insight delivered by top scientists from academia and industry."

During four plenary sessions the following topics will be covered:

  • biopharmaceutical technology
  • targeted delivery
  • diagnostics & biomarkers
  • vaccines

In addition to the scientific sessions there will be ample opportunities to network during the breaks, posters sessions, reception and conference dinner.

Especially for junior researchers a ‘Meet the Expert' session with Dr. Annemieke Geluk will be organized on the 24th of May. During an informal round table discussion PhD students and postdocs will have the exclusive opportunity to ask any question/advise related to their research and careers. If you are interested in joining the session, then send an e-mail to conferences@vib.be. Seating is limited.

Poster information:
Format: A0 (841 x 1189 mm / 33.1 x 46.8 in), portrait orientation

Share

Confirmed speakers

Mustafa Diken
Diken Mustafa - Profile picture
Mustafa Diken

Mustafa Diken

TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz, DE

Program

Day 1 - Thursday, 24 May, 2018

08:45
09:15
Registration & Coffee
09:15
09:20
Welcome by Nico Callewaert
09:20
12:40
AM Plenary session: Diagnostics & biomarkers

Chair Kris Gevaert

09:20
10:10
Managing health and disease using big data

Michael Snyder

Center for Genomics and Personalized Medicine, Stanford University, US
10:10
10:45
Novel technologies for the detection of clinically relevant DNA alterations in circulating DNA
10:45
11:15
Coffee break
11:15
11:50
Point of care diagnostics in tuberculosis and leprosy
11:50
12:25
Isolation and characterization of extracellular vesicles in liquid biopsies
12:40
13:30
Lunch
13:30
14:30
Poster session
14:30
18:10
PM Plenary session: Targeted delivery

Chair: Erik Depla

14:30
15:05
AcTakines: a novel class of cancer immunotherapeutics
15:05
15:40
Inhalation of antibody (Ab) to treat respiratory diseases (RD)
15:40
15:55
Selected talk: Therapeutic applicability of TNF receptor-1 inhibition using small single-domain antibodies
15:55
16:25
Coffee break
16:25
17:00
Addressing central nervous system target space using single-domain antibody technologies
17:00
17:35
Engineering brain delivery of therapeutics for neurodegeneration
17:35
18:10
Development of oncolytic virus vaccine technology for the treatment of cancer
18:10
19:00
Reception
20:00
23:00
Conference dinner

Day 2 - Friday, 25 May, 2018

08:45
09:15
Coffee
09:15
12:35
AM Plenary session: Biopharmaceutical technology

Chair: Nico Callewaert

09:15
10:05
TBA
10:05
10:40
Exploiting innate immune cell recognition for CAR T cell therapy for cancer
10:40
11:10
Coffee break
11:10
11:45
Nanobodies – A versatile advanced therapeutic platform
11:45
12:20
The evolution of RNA-based cancer vaccines

Mustafa Diken

TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz, DE
12:20
12:35
Selected talk: Engineering the immune system with synthetic nanomaterials
12:35
13:30
Lunch
13:30
14:30
Poster session
14:30
17:50
PM Plenary session: Vaccines

Chair: Xavier Saelens

14:30
15:05
Engineering native-like HIV-1 envelope trimers to induce neutralizing antibodies
15:05
15:40
A hemagglutinin stalk-based universal influenza virus vaccine

Florian Krammer

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, US
15:40
15:55
Selected talk: Spy and Snoop protein superglues to accelerate vaccine development
15:55
16:25
Coffee break
16:25
17:00
Development of vaccines to accelerate malaria parasite elimination and eradication
17:00
17:50
Development of trispecific antibodies for aids and cancer
17:50
18:00
Closing remarks by Kris Gevaert

Organizing committee

Abstracts

The full list of abstracts will be available on 10-05-2018 until 05-06-2018
This list will only be available for registered attendees of the event.

Attendees

The full list of attendees will be available on 10-05-2018 until 05-06-2018
This list will only be available for registered attendees of the event.